Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure

Purpose To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE). Methods Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selec...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular and interventional radiology Vol. 36; no. 3; pp. 706 - 713
Main Authors Irie, Toshiyuki, Kuramochi, Masashi, Takahashi, Nobuyuki
Format Journal Article
LanguageEnglish
Published New York Springer-Verlag 01.06.2013
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE). Methods Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed. Results Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13–64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83–100 mmHg). There was a statistically significant difference in BOASP between groups ( p  = 0.00004, Welch’s t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9–54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7–4.2). There was a statistically significant difference in the LECHL ratio between the groups ( p  = 0.000034, Welch’s t test). Conclusion Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.
AbstractList To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE). Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed. Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13-64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83-100 mmHg). There was a statistically significant difference in BOASP between groups (p = 0.00004, Welch's t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9-54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7-4.2). There was a statistically significant difference in the LECHL ratio between the groups (p = 0.000034, Welch's t test). Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.[PUBLICATION ABSTRACT]
Purpose To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE). Methods Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed. Results Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13–64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83–100 mmHg). There was a statistically significant difference in BOASP between groups ( p  = 0.00004, Welch’s t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9–54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7–4.2). There was a statistically significant difference in the LECHL ratio between the groups ( p  = 0.000034, Welch’s t test). Conclusion Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.
Purpose. To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE). Methods. Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed. Results. Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean {+-} SD) 33.8 {+-} 12.8 mmHg (range 13-64 mmHg) and that in group 2 was 92.3 {+-} 7.4 mmHg (range 83-100 mmHg). There was a statistically significant difference in BOASP between groups (p = 0.00004, Welch's t test). The LECHL ratio in group 1 was 18.3 {+-} 13.9 (range 2.9-54.2) and that in group 2 was 2.6 {+-} 1.1 (range 1.7-4.2). There was a statistically significant difference in the LECHL ratio between the groups (p = 0.000034, Welch's t test). Conclusion. Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.
To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE).PURPOSETo reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE).Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed.METHODSBalloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed.Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13-64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83-100 mmHg). There was a statistically significant difference in BOASP between groups (p = 0.00004, Welch's t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9-54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7-4.2). There was a statistically significant difference in the LECHL ratio between the groups (p = 0.000034, Welch's t test).RESULTSArterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13-64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83-100 mmHg). There was a statistically significant difference in BOASP between groups (p = 0.00004, Welch's t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9-54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7-4.2). There was a statistically significant difference in the LECHL ratio between the groups (p = 0.000034, Welch's t test).Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.CONCLUSIONSelective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.
To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE). Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed. Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13-64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83-100 mmHg). There was a statistically significant difference in BOASP between groups (p = 0.00004, Welch's t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9-54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7-4.2). There was a statistically significant difference in the LECHL ratio between the groups (p = 0.000034, Welch's t test). Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.
Author Kuramochi, Masashi
Irie, Toshiyuki
Takahashi, Nobuyuki
Author_xml – sequence: 1
  givenname: Toshiyuki
  surname: Irie
  fullname: Irie, Toshiyuki
  email: toshiyuki.irie.rq@hitachi.com
  organization: Department of Radiology, Hitachi General Hospital
– sequence: 2
  givenname: Masashi
  surname: Kuramochi
  fullname: Kuramochi, Masashi
  organization: Department of Radiology, Hitachi General Hospital
– sequence: 3
  givenname: Nobuyuki
  surname: Takahashi
  fullname: Takahashi, Nobuyuki
  organization: Department of Radiology, Tsukuba University Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22996589$$D View this record in MEDLINE/PubMed
https://www.osti.gov/biblio/22113657$$D View this record in Osti.gov
BookMark eNp9kstu1DAUhiNURKeFB2CDLLFhE7CTOI7ZDUOhSMNFapHYWY5zQl05duoLEvN-vBdOpy0IBKsjH33_8bn8R8WBdRaK4jHBzwnG7EXAuGK4xKQqccPacnevWJGmzq-u_XJQrDBhTUkoJYfFUQiXGBPaVfRBcVhVnLe046vix2uwAdBaqTQlI6N2FrkRbfWs3eAMOsnZsCS1Racwy-gUGJNJjzbSK23dJNEHNyQDaEhe26_oDAyoqL8BeiWNcc6WTimTBhjQuZc2SB_Ba2nQ5gImB1PvjN5d__wSvQcZkocJbFza-KvA-lZ7FtM0o08ewsI_LO6P0gR4dBOPi89vTs43p-X249t3m_W2VE3bxrKVY93hse96zrpe1XzkdADWjyMlvGlHyhRuxxwb3lNC6Dh0VdsAw12dlaqrj4un-7ouRC2C0hHUhXLW5oFFVRFSt5Rl6tmemr27ShCimHRY1iYtuBQEqRtec44Z-1XwDr10yds8Q6YoI13VcJKpJzdU6icYxOz1JP13cXvGDJA9oLwLwcN4hxAsFquIvVVEtopYrCJ2WcP-0ORxrs8QvdTmv8pqrwzzcnDwvzX9T9FPWhjXBA
CitedBy_id crossref_primary_10_2214_AJR_14_13683
crossref_primary_10_1586_17434440_2016_1164594
crossref_primary_10_1080_10255842_2019_1567720
crossref_primary_10_22575_interventionalradiology_2023_0009
crossref_primary_10_1111_hepr_13259
crossref_primary_10_1016_j_crad_2017_03_023
crossref_primary_10_1016_j_jvir_2018_02_005
crossref_primary_10_1111_hepr_12564
crossref_primary_10_1155_2016_1957129
crossref_primary_10_1007_s00270_018_2150_6
crossref_primary_10_1159_000439103
crossref_primary_10_1007_s00270_015_1208_y
crossref_primary_10_1007_s00270_019_02333_3
crossref_primary_10_1159_000440627
crossref_primary_10_3892_ol_2020_11758
crossref_primary_10_22575_interventionalradiology_2024_0016
crossref_primary_10_4251_wjgo_v16_i9_3752
crossref_primary_10_1159_000440628
crossref_primary_10_1016_j_jconrel_2014_03_057
crossref_primary_10_3390_jcm14020314
crossref_primary_10_3109_13645706_2015_1086381
crossref_primary_10_1080_17474124_2024_2422367
crossref_primary_10_1007_s00270_021_03035_5
crossref_primary_10_1016_j_jvir_2014_11_042
crossref_primary_10_1007_s00270_024_03779_w
crossref_primary_10_37174_2587_7593_2024_7_2_63_75
crossref_primary_10_1016_j_addr_2023_115083
crossref_primary_10_22575_interventionalradiology_2_1_1
crossref_primary_10_1159_000516613
crossref_primary_10_3390_ijms21218165
crossref_primary_10_1007_s00330_020_06911_9
crossref_primary_10_1159_000439290
crossref_primary_10_22575_interventionalradiology_2018_0001
crossref_primary_10_4236_ojrad_2018_84029
crossref_primary_10_2214_AJR_18_19975
crossref_primary_10_18528_ijgii190025
crossref_primary_10_1007_s11604_019_00836_0
crossref_primary_10_1007_s00270_015_1271_4
crossref_primary_10_3390_cancers13205129
crossref_primary_10_1007_s00270_017_1753_7
crossref_primary_10_1007_s00270_019_02192_y
crossref_primary_10_1007_s00270_015_1279_9
crossref_primary_10_1016_j_jvir_2018_11_026
crossref_primary_10_1111_hepr_12534
crossref_primary_10_1007_s00270_015_1237_6
crossref_primary_10_1007_s00270_024_03854_2
crossref_primary_10_1007_s11604_014_0292_2
crossref_primary_10_1111_hepr_12527
crossref_primary_10_18528_ijgii210042
crossref_primary_10_1186_s12876_021_01631_w
crossref_primary_10_1007_s00270_017_1719_9
crossref_primary_10_1007_s00270_013_0816_7
crossref_primary_10_1111_hepr_12403
crossref_primary_10_3390_jpm12030436
crossref_primary_10_2214_AJR_15_14825
crossref_primary_10_3390_app10207337
crossref_primary_10_3390_jcm11185334
crossref_primary_10_1007_s00270_021_02968_1
crossref_primary_10_1186_s40064_016_1880_7
crossref_primary_10_1177_2047981614545910
crossref_primary_10_1002_hep4_2016
crossref_primary_10_1016_j_clinimag_2021_11_026
crossref_primary_10_1111_hepr_12912
crossref_primary_10_1016_j_jvir_2019_05_033
crossref_primary_10_1080_13645706_2017_1398174
crossref_primary_10_1007_s00270_021_02805_5
crossref_primary_10_3350_cmh_2020_0204
crossref_primary_10_4254_wjh_v10_i7_485
crossref_primary_10_1111_hepr_12754
crossref_primary_10_3390_cancers15204991
crossref_primary_10_1155_2020_9289321
crossref_primary_10_6009_jjrt_2016_JSRT_72_10_1039
crossref_primary_10_3748_wjg_v20_i37_13453
crossref_primary_10_1007_s00330_016_4573_2
crossref_primary_10_3390_pharmaceutics15061664
crossref_primary_10_1371_journal_pone_0183861
crossref_primary_10_1002_cnm_2983
crossref_primary_10_1016_j_jvir_2017_09_015
crossref_primary_10_2217_hep_2015_0001
crossref_primary_10_1371_journal_pone_0145546
crossref_primary_10_22575_interventionalradiology_2017_0003
crossref_primary_10_1016_j_jceh_2025_102538
crossref_primary_10_4254_wjh_v6_i12_844
crossref_primary_10_1007_s00330_022_09284_3
crossref_primary_10_2342_ymj_65_15
crossref_primary_10_1111_hepr_12450
crossref_primary_10_3390_biology10121341
crossref_primary_10_1016_j_jvir_2021_10_015
crossref_primary_10_1111_hepr_12579
crossref_primary_10_1007_s11547_024_01816_9
crossref_primary_10_3390_diseases11040149
crossref_primary_10_1007_s10396_013_0487_7
crossref_primary_10_12677_acm_2025_152413
crossref_primary_10_1007_s00270_021_02973_4
crossref_primary_10_3390_cryst13020194
crossref_primary_10_3109_13645706_2014_951657
crossref_primary_10_3350_cmh_2023_0102
crossref_primary_10_1016_j_redii_2024_100048
crossref_primary_10_1155_2019_8350926
crossref_primary_10_1016_j_jvir_2018_12_014
crossref_primary_10_51821_84_1_109
crossref_primary_10_1371_journal_pone_0222553
crossref_primary_10_4264_numa_74_6_308
Cites_doi 10.1053/jhep.2002.33156
10.1148/radiol.2371040919
10.3109/02841858909174710
10.1097/SLA.0b013e3181571047
10.1016/j.jvir.2006.12.004
10.2214/ajr.146.4.735
10.1002/cncr.25283
10.1053/jhep.2003.50047
10.1007/s002700010070
10.1002/hep.510310203
10.1148/radiology.167.2.2833765
10.1148/radiology.168.2.2839866
10.1148/radiology.147.2.6836115
10.1148/radiology.201.3.8939223
ContentType Journal Article
Copyright Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012
Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2013
Copyright_xml – notice: Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012
– notice: Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TO
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
OTOTI
DOI 10.1007/s00270-012-0476-z
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Proquest Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
OSTI.GOV
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Oncogenes and Growth Factors Abstracts


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-086X
EndPage 713
ExternalDocumentID 22113657
2984697321
22996589
10_1007_s00270_012_0476_z
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29B
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z7X
Z7Y
Z82
Z87
Z8O
Z8S
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7TO
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
AAFGU
AAPBV
ABFGW
ABKAS
ACBMV
ACBRV
ACBYP
ACIGE
ACIPQ
ACTTH
ACVWB
ACWMK
ADMDM
AEFTE
AESTI
AEVTX
AGGBP
AIMYW
AJDOV
AKQUC
OTOTI
UNUBA
Z7V
Z83
Z8P
Z8W
ID FETCH-LOGICAL-c466t-6af380fb8b978bc39f95de7bff51946f57c06f6f549b5115fd8264e7083af3c83
IEDL.DBID U2A
ISSN 0174-1551
1432-086X
IngestDate Thu May 18 18:33:23 EDT 2023
Tue Aug 05 11:07:30 EDT 2025
Sat Jul 26 03:09:30 EDT 2025
Mon Jul 21 06:03:49 EDT 2025
Tue Jul 01 00:48:11 EDT 2025
Thu Apr 24 22:48:44 EDT 2025
Fri Feb 21 02:34:35 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Therapeutic blockade
Hepatic arteries
Chemotherapeutic infusion
Liver
Liver neoplasms
Blood supply
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-6af380fb8b978bc39f95de7bff51946f57c06f6f549b5115fd8264e7083af3c83
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 22996589
PQID 1357182491
PQPubID 54058
PageCount 8
ParticipantIDs osti_scitechconnect_22113657
proquest_miscellaneous_1349399077
proquest_journals_1357182491
pubmed_primary_22996589
crossref_primary_10_1007_s00270_012_0476_z
crossref_citationtrail_10_1007_s00270_012_0476_z
springer_journals_10_1007_s00270_012_0476_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-06-01
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Vienna
PublicationTitle Cardiovascular and interventional radiology
PublicationTitleAbbrev Cardiovasc Intervent Radiol
PublicationTitleAlternate Cardiovasc Intervent Radiol
PublicationYear 2013
Publisher Springer-Verlag
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer Nature B.V
References Nakamura, Hashimoto, Oi, Sawada (CR7) 1988; 167
Raoul, Bourguet, Bretagne (CR12) 1988; 168
Moriyasu, Nishida, Ban (CR9) 1986; 146
Demachi, Matsui, Abo, Tatsu (CR10) 2000; 23
Llovet, Bruix (CR1) 2003; 37
de Baere, Zhang, Aubert (CR11) 1996; 201
Kan, Ivancev, Hägerstrand (CR8) 1989; 30
Ekataksin (CR6) 2000; 31
Miyayama, Matsui, Yamashiro (CR15) 2007; 18
Cho, Lunderquist (CR4) 1983; 147
Lau, Lai, Leung, Yu (CR13) 2008; 247
Tohma, Cho, Okazumi (CR5) 2005; 237
Irie, Kuramochi, Takahashi (CR3) 2009; 26
Lo, Ngan, Tso (CR2) 2002; 35
Chua, Chu, Butler (CR14) 2010; 116
W Ekataksin (476_CR6) 2000; 31
TC Chua (476_CR14) 2010; 116
Z Kan (476_CR8) 1989; 30
H Demachi (476_CR10) 2000; 23
T Tohma (476_CR5) 2005; 237
CM Lo (476_CR2) 2002; 35
S Miyayama (476_CR15) 2007; 18
JM Llovet (476_CR1) 2003; 37
T Baere de (476_CR11) 1996; 201
F Moriyasu (476_CR9) 1986; 146
KJ Cho (476_CR4) 1983; 147
JL Raoul (476_CR12) 1988; 168
H Nakamura (476_CR7) 1988; 167
T Irie (476_CR3) 2009; 26
WY Lau (476_CR13) 2008; 247
References_xml – volume: 35
  start-page: 1164
  year: 2002
  end-page: 1171
  ident: CR2
  article-title: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1053/jhep.2002.33156
– volume: 237
  start-page: 361
  year: 2005
  end-page: 365
  ident: CR5
  article-title: Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery
  publication-title: Radiology
  doi: 10.1148/radiol.2371040919
– volume: 167
  start-page: 415
  year: 1988
  end-page: 417
  ident: CR7
  article-title: Iodized oil in the portal vein after arterial embolization
  publication-title: Radiology
– volume: 30
  start-page: 419
  year: 1989
  end-page: 425
  ident: CR8
  article-title: In vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the Rat
  publication-title: Acta Radiol
  doi: 10.3109/02841858909174710
– volume: 247
  start-page: 43
  year: 2008
  end-page: 48
  ident: CR13
  article-title: Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial—update on 5-year and 10-year survival
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e3181571047
– volume: 18
  start-page: 365
  year: 2007
  end-page: 376
  ident: CR15
  article-title: Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas:relationship between local tumor recurrence and visualization of the portal vein with iodized oil
  publication-title: J Vasc Interv Radiol
  doi: 10.1016/j.jvir.2006.12.004
– volume: 146
  start-page: 735
  year: 1986
  end-page: 739
  ident: CR9
  article-title: “Congestion index” of the portal vein
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.146.4.735
– volume: 116
  start-page: 4069
  year: 2010
  end-page: 4077
  ident: CR14
  article-title: Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma
  publication-title: Cancer
  doi: 10.1002/cncr.25283
– volume: 26
  start-page: 49
  year: 2009
  end-page: 54
  ident: CR3
  article-title: Improved accumulation of lipiodol under balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma: measurement of blood pressure at the embolized artery before and after balloon inflation
  publication-title: IVR
– volume: 201
  start-page: 731
  year: 1996
  end-page: 735
  ident: CR11
  article-title: Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study
  publication-title: Radiology
– volume: 37
  start-page: 429
  year: 2003
  end-page: 442
  ident: CR1
  article-title: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50047
– volume: 23
  start-page: 285
  year: 2000
  end-page: 290
  ident: CR10
  article-title: Simulation model based on non-newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s002700010070
– volume: 31
  start-page: 269
  year: 2000
  end-page: 279
  ident: CR6
  article-title: The isolated artery: an intrahepatic arterial pathway that can bypass the lobular parenchyma in mammalian livers
  publication-title: Hepatology
  doi: 10.1002/hep.510310203
– volume: 168
  start-page: 541
  year: 1988
  end-page: 545
  ident: CR12
  article-title: Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases
  publication-title: Radiology
– volume: 147
  start-page: 357
  year: 1983
  end-page: 364
  ident: CR4
  article-title: The peribiliary vascular plexus: the microvascular architecture of the bile duct in the rabbit and in clinical cases
  publication-title: Radiology
– volume: 237
  start-page: 361
  year: 2005
  ident: 476_CR5
  publication-title: Radiology
  doi: 10.1148/radiol.2371040919
– volume: 37
  start-page: 429
  year: 2003
  ident: 476_CR1
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50047
– volume: 31
  start-page: 269
  year: 2000
  ident: 476_CR6
  publication-title: Hepatology
  doi: 10.1002/hep.510310203
– volume: 30
  start-page: 419
  year: 1989
  ident: 476_CR8
  publication-title: Acta Radiol
  doi: 10.3109/02841858909174710
– volume: 23
  start-page: 285
  year: 2000
  ident: 476_CR10
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s002700010070
– volume: 18
  start-page: 365
  year: 2007
  ident: 476_CR15
  publication-title: J Vasc Interv Radiol
  doi: 10.1016/j.jvir.2006.12.004
– volume: 167
  start-page: 415
  year: 1988
  ident: 476_CR7
  publication-title: Radiology
  doi: 10.1148/radiology.167.2.2833765
– volume: 168
  start-page: 541
  year: 1988
  ident: 476_CR12
  publication-title: Radiology
  doi: 10.1148/radiology.168.2.2839866
– volume: 247
  start-page: 43
  year: 2008
  ident: 476_CR13
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e3181571047
– volume: 147
  start-page: 357
  year: 1983
  ident: 476_CR4
  publication-title: Radiology
  doi: 10.1148/radiology.147.2.6836115
– volume: 146
  start-page: 735
  year: 1986
  ident: 476_CR9
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.146.4.735
– volume: 26
  start-page: 49
  year: 2009
  ident: 476_CR3
  publication-title: IVR
– volume: 116
  start-page: 4069
  year: 2010
  ident: 476_CR14
  publication-title: Cancer
  doi: 10.1002/cncr.25283
– volume: 201
  start-page: 731
  year: 1996
  ident: 476_CR11
  publication-title: Radiology
  doi: 10.1148/radiology.201.3.8939223
– volume: 35
  start-page: 1164
  year: 2002
  ident: 476_CR2
  publication-title: Hepatology
  doi: 10.1053/jhep.2002.33156
SSID ssj0015825
Score 2.3677423
Snippet Purpose To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded...
To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial...
Purpose. To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded...
SourceID osti
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 706
SubjectTerms Aged
Aged, 80 and over
Angiography, Digital Subtraction
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacokinetics
Arterial Pressure - physiology
ARTERIES
Balloon Occlusion
BRACHYTHERAPY
Carcinoma, Hepatocellular - diagnostic imaging
Carcinoma, Hepatocellular - physiopathology
Carcinoma, Hepatocellular - therapy
Cardiology
Chemoembolization, Therapeutic - methods
Clinical Investigation
CONCENTRATION RATIO
Emulsions
Ethiodized Oil - administration & dosage
Ethiodized Oil - pharmacokinetics
Female
FLUOROSCOPY
HEPATOMAS
Humans
Imaging
LIPIODOL
LIVER
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - physiopathology
Liver Neoplasms - therapy
Male
Medicine
Medicine & Public Health
Middle Aged
Nuclear Medicine
Prospective Studies
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
Tomography, X-Ray Computed
Treatment Outcome
Ultrasound
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgkRAXxLtbCjISJ5BFHk7scEFLabVC2l5Kpb1Z8UtCysalTS79f_1fzCROCir0FCnJWJZmbH_z8HyEvM9c5ZOcl0xqbxhPfc1k7TUoJC9ELawVDi8nb07K9Rn_vi22MeB2Gcsqpz1x2KhtMBgj_5SCLGBhXqVfzn8xZI3C7Gqk0LhPHmDrMrRqsZ0drrSQ2VjCKDhDaDBlNZOhiWiGlCtYmMBFya7-OpcWAdbXvzDnrXzpcAwdPyGPI36kq1HhT8k91z4jDzcxQ_6cXH8Dv9TRlTH9LjJz0eApUlSDA9rQI3iLATL6s6VrOIq6gKF7rEWlh0gr1IZdTU-C7RtHxyuM9HSgyoFdkX7FLH1oWTCm6a2zdDjphqpQMGOKzQeC2-nQxMudn-nmJgSJ07g1wGqSPe3Aruh4WfHCvSBnx0c_DtcsUjUww8uyY2Xtc5l4LTV4pdrkla8K64T2HhAiL30hTFJ6ePJKA8QrvAW3hjsBABAkjcxfkkUbWrdHaOo19vDzAM0ktz6rhag151rK1IB8siTJpChlYh9zpNNo1NyBedCtAt0q1K26WpIPs8j52MTjrp8PUPsKEAi20TVYb2Q6lWXIflMI-DxZhYrL_VLdGOeSvJs_w0JFFdatCz3-wytAg4mAIV6N1jRPJgNQAFCwWpKPk3n9Mfj_Zrp_91Rek0fZyN0BZn5AFt1F794Agur022GZ_AYKIxr-
  priority: 102
  providerName: ProQuest
Title Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure
URI https://link.springer.com/article/10.1007/s00270-012-0476-z
https://www.ncbi.nlm.nih.gov/pubmed/22996589
https://www.proquest.com/docview/1357182491
https://www.proquest.com/docview/1349399077
https://www.osti.gov/biblio/22113657
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA_eHogv4rd7nksEn5RAm6ZN6lvv3HNRdhHPhfWpNGkCQreRu_bl_r_7v5zpl8qdgk-BNhkCM8n8JvNFyGtuUxdEImFKO8NE6AqmCqeBIVEsC1mW0mJy8nqTrLbi4y7eDXncl2O0--iS7G7qKdkNLSgMouIsEDJhVwfkMAbTHeO4tjybXAex4n3cohQM8cDoyryNxB_KaObhUN0GNG84STvdc_aA3B9AI816Lj8kd2z9iNxdD27xx-T6PRijlmbGtPuhHRf1jmJfarA6K7qEr_gqRr_XdAX6p_H4Xo8BqPQUewnVfl_QjS_bytI-b5Ged_1x4CqkJ-ia9zXzxlRtaUvaqbcuFBRkl2LFAW_32ldDRuc7uv717ojbuEEgG9eeNyBMtM9QvLBPyPZs-fV0xYb-DMyIJGlYUrhIBU4rDaaoNlHq0ri0UjsHsFAkLpYmSByMItWA62JXgi0jrATUByuNip6SWe1r-5zQ0Gks3OcAjylROl5IWWghtFKhgfXBnAQjo3IzFC_HHhpVPpVd7nibA29z5G1-NSdvpiU_-sod_5p8jNzPAXZg7VyDQUamyTnHljexhN-jVOTDGb_MQ5BmsM5EGs7Jq-k3nE5kYVFb3-IckQIEDCSQeNZL07QZDkgA8F86J29H8fqN-N92evRfs1-Qe7zv3wFSf0xmzUVrXwKKavSCHMidXJDD7MO3T0sYT5abz18W3Vn6CdhDHA4
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIgEXxJstBYwEF5BF4jhxgoTQ0oe2tLuXttLeTOzYElI27iMRoj-Kf8H_YiaPLajQW0-Rkoxlacbjbzzj-Qh5zW3mgkgkLNXOMBG6nKW506CQKJa5LApp8XLybJ5Mj8SXRbxYIz-HuzBYVjn4xNZRF97gGfn7EGQBC4ss_HR8wpA1CrOrA4VGZxZ79sd3CNnOPu5ugX7fcL6zfbg5ZT2rADMiSWqW5C5KA6dTDQGUNlHmsriwUjsHYEYkLpYmSBw8RaYBjcSuAAQurASsApImjWDcG-QmbLwBBntysQrwwjjlXcmkFAyhyJBFDdqmpRwpXrAQQsiEnf-1D448rOd_YdxL-dl229u5R-72eJVOOgO7T9Zs9YDcmvUZ-Yfk1xbEwZZOjGmWPRMY9Y4iJTYEvCXdhrd4IEe_VXQKW1_tMVWAta90E2mMKr_M6dwXTWlpd2WSHrTUPOCF6WesCvAV88aUTWEL2u6sbRUqLBuKzQ68XWpf9pdJP9DZxZEnTuPSAJNB9qAGO6bd5chT-4gcXYsSH5NR5Sv7lNDQaewZ6AAKpqJwPJcy10LoNA0NyAdjEgyKUqbvm470HaVadXxudatAtwp1q87H5O1K5LhrGnLVzxuofQWIB9v2GqxvMrXiHNl2YgmfB6tQvXs5UxeLYUxerT6DY0AV5pX1Df4jMkCfgYQhnnTWtJoMBxAC0DMbk3eDef0x-P9mun71VF6S29PD2b7a353vPSN3eMcbAia_QUb1aWOfA3qr9Yt2yVDy9brX6G8hzVgF
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVqq4IN5sKWAkuICiJo4TJ0gIbbu72lJ2VVEq9WZix5aQsnEfWSH607jzv5jJq6BCbz1FSjKWpZmxv_GM5yPkFTOp9UMee4my2uOBzbwkswoUEkYiE3kuDF5Oni_i2RH_eBwdr5Gf3V0YLKvs1sR6oc6dxjPy7QBkAQvzNNi2bVnEwXj64eTUQwYpzLR2dBqNieybH98hfDt_vzcGXb9mbDr5sjvzWoYBT_M4rrw4s2HiW5UoCKaUDlObRrkRyloANjy2kdB-bOHJUwXIJLI5oHFuBOAWkNRJCOPeIusCo6IBWd-ZLA4-9zmMKGFNAaXgHgKTLqfq1y1MGRK-YFkEF7F38deuOHDg3f9CvFeytfUmOL1L7rTolY4ac7tH1kx5n2zM2_z8A_JrDFGxoSOtV8uWF4w6S5EgG8Lfgk7gLR7P0W8lncFGWDlMHGAlLN1FUqPSLTO6cPmqMLS5QEkPa6IeWJPpDtYIuNJzWher3OS03mfrmlRwIoqtD5xZKle0V0vf0fnlAShO48oAo072sAKrps1VyTPzkBzdiBofkUHpSvOE0MAq7CBoARgmPLcsEyJTnKskCTTI-0Pid4qSuu2ijmQehez7P9e6laBbibqVF0Pyphc5aVqIXPfzFmpfAv7BJr4aq510JRlD7p1IwOfOKmS72JzLS9cYkpf9Z1gmUIVZadwK_-EpYFFfwBCPG2vqJ8MAkgAQTYfkbWdefwz-v5luXj-VF2QD_FN-2lvsPyW3WUMiAha_RQbV2co8AyhXqeetz1Dy9abd9DcC7V2g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dense+Accumulation+of+Lipiodol+Emulsion+in+Hepatocellular+Carcinoma+Nodule+during+Selective+Balloon-occluded+Transarterial+Chemoembolization%3A+Measurement+of+Balloon-occluded+Arterial+Stump+Pressure&rft.jtitle=Cardiovascular+and+interventional+radiology&rft.au=Irie%2C+Toshiyuki&rft.au=Kuramochi%2C+Masashi&rft.au=Takahashi%2C+Nobuyuki&rft.date=2013-06-01&rft.pub=Springer-Verlag&rft.issn=0174-1551&rft.eissn=1432-086X&rft.volume=36&rft.issue=3&rft.spage=706&rft.epage=713&rft_id=info:doi/10.1007%2Fs00270-012-0476-z&rft.externalDocID=10_1007_s00270_012_0476_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0174-1551&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0174-1551&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0174-1551&client=summon